Effects of Angiotensin II and the AT1 Receptor Antagonist Losartan on the Renal Excretion of Urodilatin

Publisher： Karger

E-ISSN： 1423-0143|24|2|79-83

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.24, Iss.2, 2001-06, pp. : 79-83

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiotensin II Type 1 Receptor Antagonist, Losartan, Causes Regression of Left Ventricular Hypertrophy in End-Stage Renal Disease

By  

Nephron, Vol. 90, Iss. 3, 2002-02 ,pp. : 256-261

Karger

Access to resources Recommend Favorite

Effects of Angiotensin-Converting Enzyme Inhibitor, Angiotensin II Receptor Antagonist and Calcium Antagonist on Urinary Podocytes in Patients with IgA Nephropathy

By  

American Journal of Nephrology, Vol. 20, Iss. 5, 2000-11 ,pp. : 373-379

Karger

Access to resources Recommend Favorite

Effects of an Angiotensin II Receptor Antagonist and Angiotensin-Converting Enzyme Inhibitors on Burst Forming Units-Erythroid in Chronic Hemodialysis Patients

By  

American Journal of Nephrology, Vol. 23, Iss. 5, 2003-09 ,pp. : 287-293

Karger

Access to resources Recommend Favorite

Renal and Vascular Injury Induced by Exogenous Angiotensin II Is AT1 Receptor-Dependent

By  

Nephron, Vol. 87, Iss. 1, 2001-01 ,pp. : 66-74

Karger

Access to resources Recommend Favorite

Effects of the Angiotensin II Receptor Antagonist Candesartan Cilexetil on Blood Pressure and Proteinuria in Patients with Autosomal Dominant Polycystic Kidney Disease

By  

Nephron, Vol. 86, Iss. 3, 2000-11 ,pp. : 385-386

Karger

Access to resources Recommend Favorite